A SUCCESSFUL DOWNSTAGING OF AN IRRESECTABLE DUODENAL ADENOCARCINOMA TO A SUCCESSFUL WHIPPLE’S PROCEDURE, NEVER LOSE HOPE: A CASE REPORT

Authors

  • Maria Qubtia Shaukat Khanum Memorial Cancer Hospital and & Research Centre, Peshawar-Pakistan
  • Amer Rehman Farooqi Shaukat Khanum Memorial Cancer Hospital and & Research Centre, Peshawar-Pakistan
  • Sarah Khan Shaukat Khanum Memorial Cancer Hospital and & Research Centre, Peshawar-Pakistan
  • Syed Irfan Kabir Shaukat Khanum Memorial Cancer Hospital and & Research Centre, Peshawar-Pakistan
  • Tariq Mahmood *Shaukat Khanum Memorial Cancer Hospital and & Research Centre, Lahore-Pakistan
  • Hajira Ilyas Shaukat Khanum Memorial Cancer Hospital and & Research Centre, Peshawar-Pakistan

DOI:

https://doi.org/10.55519/JAMC-S4-13088

Keywords:

Duodenal adenocarcinoma, Palliative chemotherapy, Unresectable tumour, Surgery

Abstract

Small bowel cancer is a rare cancer that contributes to less than 5% of all gastrointestinal cancers. Whereas primary duodenal adenocarcinomas account for approximately 50% of all small bowel cancers. The annual incidence rate worldwide is less than 1 case per 100,000. The median age of presentation is 67 years. There is no gender predilection. The common histological types include adenocarcinoma, neuroendocrine tumour, Gastrointestinal stromal tumour, and lymphoma.

References

1. Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Chapter 4; Lyon: IARC Press, 2000; pp.69–92.

2. Tangkittikasem N, Boonyaarunnate T, Aswakul P, Kachintorn U, Prachayakul V. Clinical, radiologic, and endoscopic manifestations of small bowel malignancies: a first report from Thailand. Asian Pac J Cancer Prev 2015;16(18):8613–8.

3. Kawahira H, Miura F, Saigo K, Matsunaga A, Natsume T, Akai T, et al. Survival predictors of patients with primary duodenal adenocarcinoma. Int Surg 2011;96(2):111–6.

4. Hu JX, Miao XY, Zhong DW, Dai WD, Liu W, Hu W. Surgical treatment of primary duodenal adenocarcinoma. Hepato-Gastroenterology 2006;53(72):858–62.

5. Lowell JA, Rossi RL, Munson JL, Braasch JW. Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection. Arch Surg 1992;127(5):557–60.

6. Schwartz GD, Barkin JS. Small-bowel tumors detected by wireless capsule endoscopy. Dig Dis Sci 2007;52(4):1026–30.

7. You HS, Hong JW, Yun EY, Kim JJ, Lee JM, Lee SS, et al. Primary non-ampullary duodenal adenocarcinoma: a single-center experience for 15 years. Korean J Gastroenterol 2015;66(4):194–201.

8. Wang Z, Ding Z, Huang S, Zhong S. Experience in clinical diagnosis and treatment of duodenal tumors. Mol Clin Oncol 2016;5(6):731–9.

Downloads

Published

2024-12-16

How to Cite

1.
Qubtia M, Farooqi AR, Khan S, Kabir SI, Mahmood T, Ilyas H. A SUCCESSFUL DOWNSTAGING OF AN IRRESECTABLE DUODENAL ADENOCARCINOMA TO A SUCCESSFUL WHIPPLE’S PROCEDURE, NEVER LOSE HOPE: A CASE REPORT. J Ayub Med Coll Abbottabad [Internet]. 2024 Dec. 16 [cited 2025 Dec. 6];36(4 (Suppl 1):1023-6. Available from: https://www.demo.ayubmed.edu.pk/index.php/jamc/article/view/13088